Sources reveal that Bain Capital, KKR, and KV Asia Capital have made it to the final shortlist and will bid for a minority stake in Malaysian healthcare group Avisena.

This transaction has attracted the attention of several globally renowned investment institutions, demonstrating the continued optimism of international capital towards the Southeast Asian healthcare sector. The shortlisted bidders are expected to compete fiercely for the strategic investment opportunity in this premium asset. As Malaysia’s leading healthcare service provider, Avisena’s equity sale process is being closely watched by the market. The sale of a minority stake may provide the company with capital support and strategic resources, helping its regional expansion plans.